Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Undetectable Urine Calcium in a Gastric Bypass Patient.

Campbell ST, Santen RJ, Bruns DE.

Clin Chem. 2016 Aug;62(8):1161. doi: 10.1373/clinchem.2015.251868. No abstract available.

2.

Biennial [corrected] IV zoledronic acid (Reclast) for prevention of osteoporosis.

[No authors listed]

Med Lett Drugs Ther. 2009 Jun 29;51(1315):49. No abstract available. Erratum in: Med Lett Drugs Ther. 2009 Jul 27;51(1317):60.

PMID:
19556940
3.

Pharmacist-run zoledronic acid clinic.

Traina AN, Kane MP, Bakst G, Abelseth JM, Busch RS.

Am J Health Syst Pharm. 2011 Aug 1;68(15):1399-403. doi: 10.2146/ajhp100302. No abstract available.

PMID:
21785027
4.

[New bone density conservation agents for osteoporosis under research and development: Zoledronate].

Wada S, Fukawa T, Kamiya S.

Nihon Rinsho. 2007 Nov 28;65 Suppl 9:421-5. Review. Japanese. No abstract available.

PMID:
18161143
5.
6.

Spontaneously recovered severe thrombocytopaenia following zoledronic acid infusion for osteoporosis.

Kulkarni P, Cushman T, Donthireddy V, Rao S.

BMJ Case Rep. 2016 Feb 3;2016. pii: bcr2015213786. doi: 10.1136/bcr-2015-213786.

7.

Zoledronic acid: new indication. No therapeutic advantage in postmenopausal osteoporosis.

[No authors listed]

Prescrire Int. 2008 Aug;17(96):143.

PMID:
19480098
8.

Zoledronic acid: a review of its use in the treatment of osteoporosis.

Deeks ED, Perry CM.

Drugs Aging. 2008;25(11):963-86. doi: 10.2165/0002512-200825110-00007. Review.

PMID:
18947264
9.

Zoledronic acid--once-yearly. Corticosteroid-induced osteoporosis: no benefit.

[No authors listed]

Prescrire Int. 2010 Apr;19(106):63. No abstract available.

PMID:
20568485
10.
11.

Short-Term Safety of Zoledronic Acid in Young Patients With Bone Disorders: An Extensive Institutional Experience.

George S, Weber DR, Kaplan P, Hummel K, Monk HM, Levine MA.

J Clin Endocrinol Metab. 2015 Nov;100(11):4163-71. doi: 10.1210/jc.2015-2680. Epub 2015 Aug 26.

12.

Intravenous zoledronic acid for the treatment of osteoporosis.

Lewiecki EM.

Curr Osteoporos Rep. 2008 Mar;6(1):17-23. Review.

PMID:
18430396
13.

Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis.

Woodis CB.

Ann Pharmacother. 2008 Jul;42(7):1085-9. doi: 10.1345/aph.1K652. Epub 2008 May 27.

PMID:
18505912
14.

Osteonecrosis of the jaw.

Sari E, Bulut N, Altundag K.

J Am Dent Assoc. 2008 Apr;139(4):398; author reply 398-400. No abstract available.

PMID:
18385020
15.

Yearly zoledronic acid in postmenopausal osteoporosis.

Poole KE, Kaptoge S, Reeve J.

N Engl J Med. 2007 Aug 16;357(7):711-2; author reply 714-5. No abstract available.

PMID:
17703530
16.

[Bisphosphonates for osseus invasion caused by bronchial carcinoma].

Bartl R.

Dtsch Med Wochenschr. 2008 Nov;133(48):2530. doi: 10.1055/s-0028-1100953. Epub 2008 Nov 19. German. No abstract available.

PMID:
19021088
17.

[Zoledronic acid for preventing fractures. HORIZON trial (Health Outcomes and Reduced Incidence with Zoledronic acid ONce yearly)].

Ringe JD, Nitschmann S.

Internist (Berl). 2008 Apr;49(4):502-4. doi: 10.1007/s00108-008-2067-2. German. No abstract available.

PMID:
18305914
18.

Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone mass.

Hamdy RC.

Drug Des Devel Ther. 2010 Nov 18;4:321-35. doi: 10.2147/DDDT.S6287. Review.

19.

A once-yearly IV bisphosphonate for osteoporosis.

[No authors listed]

Obstet Gynecol. 2008 May;111(5):1208-9. doi: 10.1097/01.AOG.0000313748.64874.e8. No abstract available.

PMID:
18448761
20.

Atrial fibrillation following intravenous zolendronic acid for osteoporosis.

Konsta M, Bournia VK, Dania V, Iliopoulos A.

J Clin Rheumatol. 2014 Jun;20(4):239-40. doi: 10.1097/RHU.0000000000000114. No abstract available.

PMID:
24847757

Supplemental Content

Support Center